{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:16:12Z","timestamp":1790612172818,"version":"4.1.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1093\/eurheartj\/ehr231","type":"journal-article","created":{"date-parts":[[2011,7,31]],"date-time":"2011-07-31T00:26:43Z","timestamp":1312072003000},"page":"2945-2953","source":"Crossref","is-referenced-by-count":166,"title":["Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes"],"prefix":"10.1093","volume":"32","author":[{"given":"Robert F.","family":"Storey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen","family":"Husted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nardev S.","family":"Khurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Emanuelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,30]]},"reference":[{"key":"key\n\t\t\t\t20170515130532_EHR231C1","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jacc.2007.07.058","article-title":"Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes","volume":"50","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515130532_EHR231C2","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSet of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: The ONSET\/OFFSET study","volume":"120","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515130532_EHR231C3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"for the PLATO Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515130532_EHR231C4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","article-title":"Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study","volume":"375","author":"the PLATelet inhibition and patient Outcomes (PLATO) investigators","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515130532_EHR231C5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","article-title":"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin","volume":"27","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515130532_EHR231C6","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2007.07.053","article-title":"Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial","volume":"50","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515130532_EHR231C7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2010.01.062","article-title":"Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel or placebo in the ONSET\/OFFSET study","volume":"56","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515130532_EHR231C8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ahj.2009.01.003","article-title":"Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"157","year":"2009","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170515130532_EHR231C9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/japplphysiol.00913.2004","article-title":"Intravenous adenosine and dyspnea in humans","volume":"98","year":"2005","journal-title":"J Appl Physiol"},{"key":"key\n\t\t\t\t20170515130532_EHR231C10","article-title":"Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model","year":"2011","journal-title":"J Cardiovasc Pharmacol Therapeut"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/32\/23\/2945\/17049409\/ehr231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T16:10:04Z","timestamp":1560442204000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehr231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,30]]},"references-count":10,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2011,7,30]]},"published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehr231","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,30]]}}}